BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17894419)

  • 21. [A pocket pRb mutation induces the increase in its affinity to E2F4 coupled with activation of muscle differentiation].
    Popov BV; Watt SM; Rozanov IuM; Chang L-
    Mol Biol (Mosk); 2010; 44(2):323-34. PubMed ID: 20586193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin C inhibits benzo[a]pyrene-induced cell cycle changes partly via cyclin D1/E2F pathway in human embryo lung fibroblasts.
    Gao A; Liu BC; Shit XL; Huang CS; Jia XW; You BR; Ye M; Shen FH; Du HJ
    Biomed Environ Sci; 2006 Jun; 19(3):239-44. PubMed ID: 16944783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of cyclin D1/CDK4 and pRb mediated by PI3K/AKT pathway activation in Pb2+ -induced neuronal death in cultured hippocampal neurons.
    Li C; Xing T; Tang M; Yong W; Yan D; Deng H; Wang H; Wang M; Chen J; Ruan D
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):351-61. PubMed ID: 18353414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. D-type cyclins and G1 progression during liver development in the rat.
    Boylan JM; Gruppuso PA
    Biochem Biophys Res Commun; 2005 May; 330(3):722-30. PubMed ID: 15809057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interplay between the retinoblastoma related pRb2/p130 and E2F-4 and -5 in relation to JCV-TAg.
    Caracciolo V; Reiss K; Crozier-Fitzgerald C; De Pascali F; Macaluso M; Khalili K; Giordano A; Claudio PP
    J Cell Physiol; 2007 Jul; 212(1):96-104. PubMed ID: 17385710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.
    Landis MW; Pawlyk BS; Li T; Sicinski P; Hinds PW
    Cancer Cell; 2006 Jan; 9(1):13-22. PubMed ID: 16413468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.
    Gadd M; Pisc C; Branda J; Ionescu-Tiba V; Nikolic Z; Yang C; Wang T; Shackleford GM; Cardiff RD; Schmidt EV
    Cancer Res; 2001 Dec; 61(24):8811-9. PubMed ID: 11751403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IKK/NF-kappaB signaling pathway inhibits cell-cycle progression by a novel Rb-independent suppression system for E2F transcription factors.
    Araki K; Kawauchi K; Tanaka N
    Oncogene; 2008 Sep; 27(43):5696-705. PubMed ID: 18542057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of the E2F family of transcription factors during murine development.
    Kusek JC; Greene RM; Nugent P; Pisano MM
    Int J Dev Biol; 2000 Apr; 44(3):267-77. PubMed ID: 10853823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo.
    Ebelt H; Zhang Y; Kampke A; Xu J; Schlitt A; Buerke M; Müller-Werdan U; Werdan K; Braun T
    Cardiovasc Res; 2008 Nov; 80(2):219-26. PubMed ID: 18628254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGFbeta-mediated formation of pRb-E2F complexes in human myeloid leukemia cells.
    Hu XT
    Biochem Biophys Res Commun; 2008 May; 369(2):277-80. PubMed ID: 18294958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma.
    Molenaar JJ; Ebus ME; Koster J; van Sluis P; van Noesel CJ; Versteeg R; Caron HN
    Cancer Res; 2008 Apr; 68(8):2599-609. PubMed ID: 18413728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
    Rubin SM; Gall AL; Zheng N; Pavletich NP
    Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro.
    Takaki T; Fukasawa K; Suzuki-Takahashi I; Hirai H
    Biochem Biophys Res Commun; 2004 Mar; 316(1):252-5. PubMed ID: 15003538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin D3 interacts with human activating transcription factor 5 and potentiates its transcription activity.
    Liu W; Sun M; Jiang J; Shen X; Sun Q; Liu W; Shen H; Gu J
    Biochem Biophys Res Commun; 2004 Sep; 321(4):954-60. PubMed ID: 15358120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Cyclin D1-CDK4 kinase a bona fide cancer target?
    Malumbres M; Barbacid M
    Cancer Cell; 2006 Jan; 9(1):2-4. PubMed ID: 16413464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
    Yin H; Lowery M; Glass J
    Prostate; 2009 Jun; 69(9):1001-16. PubMed ID: 19347879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute renal failure during sepsis: potential role of cell cycle regulation.
    Yang QH; Liu DW; Long Y; Liu HZ; Chai WZ; Wang XT
    J Infect; 2009 Jun; 58(6):459-64. PubMed ID: 19428114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct capacities of individual E2Fs to induce cell cycle re-entry in postmitotic lens fiber cells of transgenic mice.
    Chen Q; Liang D; Yang T; Leone G; Overbeek PA
    Dev Neurosci; 2004; 26(5-6):435-45. PubMed ID: 15855772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression.
    Tashiro E; Tsuchiya A; Imoto M
    Cancer Sci; 2007 May; 98(5):629-35. PubMed ID: 17359287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.